{"DataElement":{"publicId":"6701813","version":"1","preferredName":"Anticoagulant Agent Or Other Agent Therapeutic Procedure Administered Name","preferredDefinition":"A description of the anticoagulant agent or other agent therapy that was administered.","longName":"6701753v1.0:6701755v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"6701753","version":"1","preferredName":"Anticoagulant Agent Or Other Agent Therapeutic Procedure Administered","preferredDefinition":"Agents that prevent blood clotting. Naturally occurring agents in the blood are included only when they are used as drugs._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Different than the one(s) previously specified or mentioned._An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._The act of having given something (e.g., a medication or test).","longName":"6701006v1.0:2233610v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"6701006","version":"1","preferredName":"Anticoagulant Agent Or Other Agent Therapeutic Procedure","preferredDefinition":"Agents that prevent blood clotting. Naturally occurring agents in the blood are included only when they are used as drugs.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:Different than the one(s) previously specified or mentioned.:An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.:An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","longName":"6701006v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anticoagulant Agent","conceptCode":"C263","definition":"Any agent capable of preventing blood clot formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86C0C6E0-59C3-21A8-E053-F662850AD1D3","latestVersionIndicator":"Yes","beginDate":"2019-04-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-04-17","modifiedBy":"ONEDATA","dateModified":"2019-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86C535B2-8E59-6F18-E053-F662850A00A3","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-04-18","modifiedBy":"KUMMEROA","dateModified":"2020-01-30","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6701755","version":"1","preferredName":"Anticoagulant Agent Or Other Agent Name","preferredDefinition":"Any agent capable of preventing blood clot formation._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Different than the one(s) previously specified or mentioned._An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._The words or language units by which a thing is known.","longName":"6701755v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other agent","valueDescription":"Other Agent","ValueMeaning":{"publicId":"3202962","version":"1","preferredName":"Other Agent","longName":"3202962","preferredDefinition":"Different than the one(s) previously specified or mentioned.: An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E727F7D-AEBB-154D-E040-BB89AD4315DA","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-03-14","modifiedBy":"MAESKEB","dateModified":"2020-01-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86CDA855-3B47-7D23-E053-F662850A4E7F","beginDate":"2019-04-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","deletedIndicator":"No"},{"value":"Citrate phosphate dextrose","valueDescription":"Citrate Phosphate Dextrose","ValueMeaning":{"publicId":"2747083","version":"1","preferredName":"Citrate Phosphate Dextrose","longName":"2747083","preferredDefinition":"A solution of citric acid, sodium citrate, monobasic  sodium phosphate, and dextrose in water used as an anticoagulant in the  collection and preservation of whole blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Citrate Phosphate Dextrose","conceptCode":"C71605","definition":"A solution of citric acid, sodium citrate, monobasic sodium phosphate, and dextrose in water used as an anticoagulant in the collection and preservation of whole blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C926488-BE3F-129F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-05-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86CDA855-3B6F-7D23-E053-F662850A4E7F","beginDate":"2013-08-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","deletedIndicator":"No"},{"value":"Ethylenediaminetetraacetic acid (EDTA)","valueDescription":"Edetic Acid","ValueMeaning":{"publicId":"3210682","version":"1","preferredName":"Edetic Acid","longName":"3210682","preferredDefinition":"The acid form of edetate, a chelating agent with anti-hypercalcemic and anticoagulant properties. Edetic acid binds calcium and heavy metal ions, forming soluble stable complexes which are readily excreted by the kidneys. This results in a decrease in serum calcium levels. This agent is also used as an anticoagulant for blood specimens and is applied as a treatment of lead poisoning.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Edetic Acid","conceptCode":"C61742","definition":"The acid form of edetate, a chelating agent with anti-hypercalcemic and anticoagulant properties. Edetic acid binds calcium and heavy metal ions, forming soluble stable complexes which are readily excreted by the kidneys. This results in a decrease in serum calcium levels. This agent is also used as an anticoagulant for blood specimens and is applied as a treatment of lead poisoning.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E0A8-E413-4837-E040-BB89AD437666","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"KUMMEROA","dateModified":"2023-03-13","changeDescription":null,"administrativeNotes":"2023.3.13 Alt VM added per ticket request CADSR0002119. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86C551EF-FF1E-7960-E053-F662850AF665","beginDate":"2019-03-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","deletedIndicator":"No"},{"value":"Heparin","valueDescription":"Heparin","ValueMeaning":{"publicId":"2567254","version":"1","preferredName":"Heparin","longName":"2567254","preferredDefinition":"A sulfur-rich glycosaminoglycan with anticoagulant property. Heparin binds to antithrombin III to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors, such as factors IX, X, XI, and XII, thereby preventing the polymerization of fibrinogen to fibrin and the subsequent formation of clots.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Heparin","conceptCode":"C539","definition":"A sulfur-rich glycosaminoglycan with anticoagulant property. Heparin binds to antithrombin III to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors, such as factors IX, X, XI, and XII, thereby preventing the polymerization of fibrinogen to fibrin and the subsequent formation of clots.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D3C3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CURTIST","dateModified":"2011-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86C551EF-FF28-7960-E053-F662850AF665","beginDate":"2013-08-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","deletedIndicator":"No"},{"value":"Acid citrate dextrose","valueDescription":"Acid-Citrate-Dextrose","ValueMeaning":{"publicId":"2739612","version":"1","preferredName":"Acid-Citrate-Dextrose","longName":"2739612","preferredDefinition":"A citrate anticoagulant used for the collection and preservation of whole blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acid-Citrate-Dextrose","conceptCode":"C63375","definition":"A solution of citric acid, sodium citrate, and dextrose used as an anticoagulant in the collection and preservation of whole blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A894181-3DFD-24CB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86CDA855-3B5B-7D23-E053-F662850A4E7F","beginDate":"2013-08-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6701754","version":"1","preferredName":"Anticoagulant Agent Or Other Agent Name","preferredDefinition":"Agents that prevent blood clotting. Naturally occurring agents in the blood are included only when they are used as drugs.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:Different than the one(s) previously specified or mentioned.:An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.:The words or language units by which a thing is known.","longName":"6701754v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anticoagulant Agent","conceptCode":"C263","definition":"Any agent capable of preventing blood clot formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86C551EF-FEE3-7960-E053-F662850AF665","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86C551EF-FEF4-7960-E053-F662850AF665","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-04-18","modifiedBy":"KUMMEROA","dateModified":"2020-01-30","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"inf_pr_col_anticoag_oth_agt_ty","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the anticoagulant ag","type":"Preferred Question Text","description":"What was the anticoagulant agent or other agent therapy that was administered?","url":null,"context":"NHLBI"},{"name":"Specify anticoagulant(s) or other agents","type":"Alternate Question Text","description":"Specify anticoagulant(s) or other agents","url":null,"context":"NHLBI"},{"name":"Specify anticoagulant(s) or other agents","type":"Application Standard Question Text","description":"Specify anticoagulant(s) or other agents","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86C37155-5777-5E5F-E053-F662850AA70C","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-04-18","modifiedBy":"KUMMEROA","dateModified":"2020-01-30","changeDescription":". System generated def displayed as alt def.; System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}